Arkema and CJ Cheil-Jedang select Malaysia for their Bio-Methionine and Thiochemicals plants
After a long and thorough study on the best place to build their plants, CJ Cheil-Jedang and Arkema have selected the site of Kerteh, in the state of Terengganu in Malaysia.
Thanks to the best efforts of the Government of Malaysia, the Malaysian Biotechnology Corporation and the East Coast Economic Region Development Council, attractive conditions for the bio-methionine and thiochemicals plants have been obtained.
Kerteh located on the East Coast of Malaysia is an ideal place to build a thiochemical platform and bio-methionine plant where all the necessary infrastucture, utilities and raw materials can be easily obtained.The onsite bulk port and the nearby Kuantan and Kemaman container ports will facilitate the logistic of the products.
Arkema and CJ Cheil-Jedang confirm their intention to start operating the plants at the end of 2013.
Other news from the department manufacturing

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
CVS/pharmacy
John_Maddox
Chiron Delivers FLUVIRIN(R) Influenza Virus Vaccine to U.S. Customer - First Shipments Mark Beginning of 2005-2006 FLUVIRIN Supply

Vyncolit N.V. - Gent, Belgium
Crompton Petroleum Additives Plans Increased Capacity for Antioxidants in Elmira, Canada

Turning hazelnut shells into potential renewable energy source
Broad US-patent issued to MediGene - Patent protects novel methods for production of therapeutic viruses
